Dan Granberg
Solna, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.
Journal: Communications medicine
Published: February 23, 2026
MRI and 18F-fluorothymidine PET-MR for the early evaluation of renal and bone marrow effects in 177Lu-DOTATATE therapy.
Journal: Endocrine oncology (Bristol, England)
Published: April 12, 2025
Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report.
Journal: Frontiers in oncology
Published: March 28, 2024
Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours.
Journal: Journal of neuroendocrinology
Published: October 14, 2022
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N.
Journal: Frontiers in pediatrics
Published: December 15, 2021
Metastatic Pheochromocytomas and Abdominal Paragangliomas.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 18, 2020
177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated with Chemotherapy: Analysis of Outcome, Safety, and Their Determinants.
Journal: Neuroendocrinology
Published: September 19, 2019
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE.
Journal: Cancers
Published: June 10, 2019
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study.
Journal: Endocrine-related cancer
Published: November 15, 2018
Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 29, 2017
Kidney dosimetry during 177Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 19, 2017
Last Updated: 09/26/2026